59th Annual Meeting of the Japanese Society of Neurology

Session information

Oral Session

[O-05] Cerebrovascular disease (medical treatment)

Wed. May 23, 2018 3:25 PM - 4:25 PM Room 7 (Royton Sapporo / Castle (1F))

Chair: Yoichiro Hashimoto(Department of Neurology, Kumamoto City Hospital)

Masaya Kumamoto1, Kazunori Toyoda1, Shinichi Wada1, Naoki Tagawa1, Takayuki Matuki1, Takuya Okata1, Akira Okamoto2, Toshiyuki Miyata1, Masafumi Ihara3, Masatoshi Koga1 (1.Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, 2.Department of Clinical Laboratory, National Cerebral and Cardiovascular Center, 3.Department of Neurology, National Cerebral and Cardiovascular Center)

Soichiro Matsubara1,3,4, Tomotaka Tanaka2, Shinya Tomari1, Naoki Makita1, Soichiro Abe2, Hiroyuki Ishiyama2, Takuro Arimizu1, Yoshitaka Yamaguchi1, Kazuyuki Nagatsuka2, Kazunori Toyoda1, Yukio Ando4, Masafumi Ihara2 (1.Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan, 2.Department of Neurology, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan, 3.Department of Neurology, Stroke Center, Saiseikai Kumamoto Hospital, Japan, 4.Department of Neurology, Graduate School of Medical Sciences, Kumamoto University)

Shizuka Harada1, Yuichiro Inatomi1, Hironori Mizutani1, Takaomi Singu1, Souichiro Matsubara1, Masaki Naganuma1, Kouichi Ikeno1, Toshiro Yonehara1, Makoto Nakajima2, Yukio Ando2 (1.Department of Neurology, Saiseikai Kumamoto Hospital, Kumamoto, 2.Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto)